Transapical Beating-heart Myectomy for the Treatment of Apical Hypertrophic Cardiomyopathy

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

July 30, 2025

Study Completion Date

December 30, 2026

Conditions
Apical Hypertrophic Cardiomyopathy
Interventions
DEVICE

Transapical beating-heart septal myectomy

We have invented a beating-heart myectomy device. Using this device, myectomy could be performed in the beating heart via a mini-thoractomy approach. The whole process of resection is monitored, navigated, and evaluated by real-time transesophageal and transthoracic echocardiography. We are now conducting the study to explore the feasibility, the safety, and the efficacy of transapical beating-heart myectomy for the treatment of apical hypertrophic cardiomyopathy.

Trial Locations (1)

430000

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Xiang Wei

OTHER